INN name:
|
Alofanib
|
||||||
Lab codes:
|
RPT-835
|
||||||
Trade name:
|
Not
yet marketed
|
||||||
Chemical
name:
|
3-{[4-Methyl-2-nitro-5-(pyridin-3-yl)phenyl]sulfamoyl}benzoic
acid
|
||||||
Molecular
formula:
|
C19H15N3O6S
|
||||||
Chemical
Structure:
|
 |
||||||
CAS Registry
Number:
|
1612888-66-0
|
||||||
Originator:
|
Russian
Pharmaceutical Technologies
|
||||||
Class:
|
Antineoplastics
|
||||||
Mechanism of
Action:
|
Type-2
fibroblast growth factor receptor antagonists
|
||||||
WHO ATC code:
|
L01
(Antineoplastic Agents)
|
||||||
EPhMRA code:
|
L1
(Antineoplastics)
|
||||||
FDA
approval:
|
Not
yet approved
|
||||||
Clinical Trials:
|
|||||||
Product Patent Expiry:
Please contact us for
patent data regarding this compound.
|
|||||||
Recent activities on the drug:
|
|||||||
Monday 31 August 2015
Alofanib
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment